Exact Mass: 391.15075360000003
Exact Mass Matches: 391.15075360000003
Found 131 metabolites which its exact mass value is equals to given mass value 391.15075360000003
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tetrahydropalmatine hydrochloride
C21H25NO4.HCl (391.1550266000001)
Tetrahydropalmatine hydrochloride (Gindarine hydrochloride) is an isoquinoline alkaloid found in several different plant species, mainly in the Corydalis genus (Yan Hu Suo). It is a potent muscle relaxant. Tetrahydropalmatine (THP) is an isoquinoline alkaloid found in several different plant species, mainly in the genus Corydalis (Yan Hu Suo),[1][2] but also in other plants such as Stephania rotunda.[3] These plants have traditional uses in Chinese herbal medicine. The pharmaceutical industry has synthetically produced the more potent enantiomer Levo-tetrahydropalmatine (Levo-THP), which has been marketed worldwide under different brand names as an alternative to anxiolytic and sedative drugs of the benzodiazepine group and analgesics such as opiates. It is also sold as a dietary supplement. In 1940, a Vietnamese scientist Sang Dinh Bui extracted an alkaloid from the root of Stephania rotunda with the yield of 1.2–1.5\\\\% and he named this compound rotundine. From 1950 to 1952, two Indian scientists studied and extracted from Stephania glabra another alkaloid named hyndanrine. In 1965, the structure of rotundine and hyndarin was proved to be the same as tetrahydropalmatine.[4] 6H-Dibenzo[a,g]quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, hydrochloride (1:1). CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=2506-20-9 (retrieved 2024-07-09) (CAS RN: 6024-85-7). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Tetrahydropalmatine (DL-Tetrahydropalmatine) hydrochloride possesses analgesic effects. Tetrahydropalmatine hydrochloride acts through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats[1]. Tetrahydropalmatine (DL-Tetrahydropalmatine) hydrochloride possesses analgesic effects. Tetrahydropalmatine hydrochloride acts through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats[1]. Tetrahydropalmatine (DL-Tetrahydropalmatine) hydrochloride possesses analgesic effects. Tetrahydropalmatine hydrochloride acts through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats[1].
8-Methylaminoriboflavin
C17H21N5O6 (391.14917660000003)
Icotinib
C22H21N3O4 (391.15319860000005)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
2,3,10-trimethoxy-14-methyl-5-oxo-5,7,8,13-tetrahydro-indolo[2,3:3,4]pyrido[2,1-b]quinazolinium betaine|Euxylophorin-C|Euxylophorine C
C22H21N3O4 (391.15319860000005)
1-(2-hydroxy-3-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-propan-2-one|11-Acetonyl-O-desmethyl-Dihydroniditin
C23H21NO5 (391.14196560000005)
O-[alpha-L-Arabinopyranosyl(1?6)-beta-D-glucopyranoside-2-Hydroxy-3-methyl-2-butenenitrile
6-Acetonyl-N-methyl-dihydrodecarine
C23H21NO5 (391.14196560000005)
1-(3-hydroxy-2-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-propan-2-one|Acetonyl-11-O-Desmethyl-Dihydroniditin
C23H21NO5 (391.14196560000005)
1-(1-hydroxy-2-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-propan-2-one|O-Demethyldihydrochelerythrinyl-11-aceton
C23H21NO5 (391.14196560000005)
Ala Ala Cys Gln
Ala Ala Gln Cys
Ala Cys Ala Gln
Ala Cys Gln Ala
Ala Gly Met Asn
Ala Gly Asn Met
Ala Met Gly Asn
Ala Met Asn Gly
Ala Asn Gly Met
Ala Asn Met Gly
Ala Gln Ala Cys
Ala Gln Cys Ala
Cys Ala Ala Gln
Cys Ala Gln Ala
Cys Gly Asn Val
Cys Gly Val Asn
Cys Asn Gly Val
Cys Asn Val Gly
Cys Gln Ala Ala
Cys Val Gly Asn
Cys Val Asn Gly
Gly Ala Met Asn
Gly Ala Asn Met
Gly Cys Asn Val
Gly Cys Val Asn
Gly Gly Met Gln
Gly Gly Gln Met
Gly Met Ala Asn
Gly Met Gly Gln
Gly Met Asn Ala
Gly Met Gln Gly
Gly Asn Ala Met
Gly Asn Cys Val
Gly Asn Met Ala
Gly Asn Val Cys
Gly Gln Gly Met
Gly Gln Met Gly
Gly Val Cys Asn
Gly Val Asn Cys
Met Ala Gly Asn
Met Ala Asn Gly
Met Gly Ala Asn
Met Gly Gly Gln
Met Gly Asn Ala
Met Gly Gln Gly
Met Asn Ala Gly
Met Asn Gly Ala
Met Gln Gly Gly
Asn Ala Gly Met
Asn Ala Met Gly
Asn Cys Gly Val
Asn Cys Val Gly
Asn Gly Ala Met
Asn Gly Cys Val
Asn Gly Met Ala
Asn Gly Val Cys
Asn Met Ala Gly
Asn Met Gly Ala
Asn Val Cys Gly
Asn Val Gly Cys
Gln Ala Ala Cys
Gln Ala Cys Ala
Gln Cys Ala Ala
Gln Gly Gly Met
Gln Gly Met Gly
Gln Met Gly Gly
Val Cys Gly Asn
Val Cys Asn Gly
Val Gly Cys Asn
Val Gly Asn Cys
Val Asn Cys Gly
Val Asn Gly Cys
Lys-His-OH
C17H21N5O6 (391.14917660000003)
Tetrabutylammonium dichlorobromate
C16H36BrCl2N (391.14080160000003)
Fluoroclebopride
Fluoroclebopride binds reversibly to dopamine receptors. 18F labeled fluoroclebopride has been used as a probe for studying D2/D3 receptor availability via PET in various monkey models[1][2].
Fmoc-(R)-3-Amino-4-(2-furyl)-butyric acid
C23H21NO5 (391.14196560000005)
3-((BENZYLOXY)METHYL)-4-ISOPROPYL-1-(4-(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-5(4H)-ONE
C20H20F3N3O2 (391.15075360000003)
3-3-(Trifluoromethyl)benzoylaminobenzene-boronic acid pinacol ester
C20H21BF3NO3 (391.15665020000006)
Latrepirdine
C21H27Cl2N3 (391.15819220000003)
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Latrepirdine dihydrochloride is a neuroactive compound with antagonist activity at histaminergic, α-adrenergic, and serotonergic receptors. Latrepirdine stimulates amyloid precursor protein (APP) catabolism and amyloid-β (Aβ) secretion.
Fmoc-(S)-3-Amino-4-(2-furyl)-butyric acid
C23H21NO5 (391.14196560000005)
2-[5,6-Bis-(4-methoxy-phenyl)-furo[2,3-d]pyrimidin-4-ylamino]-ethanol
C22H21N3O4 (391.15319860000005)
5-tert-butyl-3-(4-chlorophenyl)-N-(2-pyridinylmethyl)-7-pyrazolo[1,5-a]pyrimidinamine
C22H22ClN5 (391.15636420000004)
Icotinib
C22H21N3O4 (391.15319860000005)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
[(3S)-3-acetamido-4-[[(2S)-1-[[(1S)-1-carboxy-3-methylbutyl]amino]-1-oxopropan-2-yl]amino]-4-oxobutyl]-oxido-oxophosphanium
6,7-diethoxy-3-[3-(2-oxo-1-pyrrolidinyl)propyl]-2-sulfanylidene-1H-quinazolin-4-one
C19H25N3O4S (391.15656900000005)
2-Hydroxybenzoic acid [2-(2-ethoxyanilino)-2-oxo-1-phenylethyl] ester
C23H21NO5 (391.14196560000005)
(4E)-4-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-2,3-dihydro-1H-acridine-9-carboxylic acid
C23H21NO5 (391.14196560000005)
1-[(1S,2aR,8bR)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
1-[(1R,2aS,8bS)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
1-[(1S,2aS,8bS)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
1-[(1R,2aR,8bR)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
1-(4-Nitrophenyl)-3-[(Z)-(1,3,3-trimethylindol-2-ylidene)methyl]pyrrolidine-2,5-dione
C22H21N3O4 (391.15319860000005)
8-Methylamino-riboflavin
C17H21N5O6 (391.14917660000003)